ID | 65041 |
フルテキストURL | |
著者 |
Asano, Yosuke
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Matsumoto, Yoshinori
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
researchmap
Wada, Jun
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
Rottapel, Robert
Princess Margaret Cancer Center, University Health Network, University of Toronto
|
抄録 | Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and proteasome. We and others have recently provided genetic evidence showing that E3-ubiquitin ligases are associated with bone metabolism, the immune system and inflammation through ubiquitylation and subsequent degradation of their substrates. Dysregulation of the E3-ubiquitin ligase RNF146-mediated degradation of the adaptor protein 3BP2 (SH3 domain-binding protein 2) causes cherubism, an autosomal dominant disorder associated with severe inflammatory craniofacial dysmorphia syndrome in children. In this review, on the basis of our discoveries in cherubism, we summarize new insights into the roles of E3-ubiquitin ligases in the development of human disorders caused by an abnormal osteoimmune system by highlighting recent genetic evidence obtained in both human and animal model studies.
|
キーワード | E3-ubiquitin ligases
ubiquitylation
proteasomal degradation
osteoimmunology
cherubism
|
発行日 | 2023-02-23
|
出版物タイトル |
Frontiers in Immunology
|
巻 | 14巻
|
出版者 | Frontiers Media
|
開始ページ | 1120710
|
ISSN | 1664-3224
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © 2023 Asano, Matsumoto, Wada and Rottapel.
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.3389/fimmu.2023.1120710
|
ライセンス | https://creativecommons.org/licenses/by/4.0/
|
Citation | Asano Y, Matsumoto Y, Wada J and Rottapel R (2023) E3-ubiquitin ligases and recent progress in osteoimmunology. Front. Immunol. 14:1120710. doi: 10.3389/fimmu.2023.1120710
|